eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Cephalon (UK) Limited

Teva UK Limited, Field House, Station Approach, Harlow, Essex, CM20 2FB
Telephone: +44 (0) 207 5407117
Fax: +44 (0) 207 4507349
WWW: http://www.tevauk.com
Medical Information Direct Line: +44 (0) 207 5407117
Medical Information e-mail: medinfo@tevauk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 05/07/2011
PIL Gabitril 5 mg, Gabitril 10 mg, Gabitril 15 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 05/05/2010 and displayed until 05/07/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 18/03/2009 and displayed until 05/05/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/01/2009 and displayed until 18/03/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 09/01/2009 and displayed until 12/01/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 15/10/2008 and displayed until 09/01/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 24/04/2008 and displayed until 15/10/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/03/2008 and displayed until 24/04/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to name of manufacturer
  • Change of inactive ingredient
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 06/07/2004 and displayed until 13/03/2008
Reasons for adding or updating:
  • Change of manufacturer
  • Change to Further Information section
Updated on 07/01/2003 and displayed until 06/07/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   tiagabine hydrochloride monohydrate